Author

C. Asquith

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

C. Hopkins· 1 shared C. I. Wells· 1 shared D. C. Morris· 1 shared D. H. Drewry· 1 shared D. K. Treiber· 1 shared G. L. Johnson· 1 shared K. Naegeli· 1 shared M. P. East· 1 shared

Activity by Year

2018-2018 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

C. Hopkins

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Design of a GAK/EGFR inhibitor set to interrogate the relationship of EGFR and GAK in chordoma

C. Asquith, K. Naegeli, M. P. East, T. Laitinen, T. M. Havener, C. I. Wells, G. L. Johnson, D. H. Drewry, W. J. Zuercher, D. C. Morris

The paper designs a set of GAK/EGFR inhibitors to study their relationship in chordoma and characterizes their activity in vitro and through target engagement assays.

bioRxiv · Nov 20, 2018Pharmacology & Toxicology

Utilizing comprehensive and mini-kinome panels to optimize the selectivity of quinoline inhibitors for cyclin G associated kinase (GAK)

C. Asquith, C. Hopkins, D. K. Treiber, W. Zuercher

The paper demonstrates using kinase mini-panels and kinome-wide panels to develop a selective quinoline inhibitor for cyclin G associated kinase (GAK).

bioRxiv · Nov 17, 2018Pharmacology & Toxicology